E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/8/2005 in the Prospect News Biotech Daily.

Jefferies maintains PDI at hold

PDI, Inc. was maintained by Jefferies & Co. Inc. analyst David Windley at a hold rating with a $12 price target after third-quarter results showed weaker losses of $0.30 per share and much higher costs than anticipated. Jefferies said it believes management still is grappling with formulation of a satisfactory turnaround plan with expense cutting as a key focus. Jefferies said management is not in a position to guide for the fourth quarter, let alone for 2006. Shares of the Saddle River, N.J.-based pharmaceutical sales and marketing outsourcing company were up $0.10, or 0.77%, at $13.15 on volume of 34,844 shares versus the three-month running average of 56,598.5 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.